Navigation Links
Nitrous gases and zinc in the crosshairs
Date:7/28/2009

particular substance causes cancer, has a mutagenic effect on gametes or poses a risk to unborn children during pregnancy. Analyses of the substances' sensitising and skin resorption effects were also performed.

In the carcinogenic substances category there are, this year, a total of seven revisions or alterations. These include the categorisation of the chromates (except lead and barium chromate) as carcinogenic in humans. According to the new MAK and BAT Values List, chromium (VI) compounds damage gametes and cause skin sensitivity. They received an "H" warning, which means that absorption via the skin can significantly contribute to the substance's toxicity. The Commission also checked 13 substances for pregnancy risks. These include di-n-butyl phthalate from the phthalates group, phenyltin compounds, phosphine, propionic acid, zinc and its inorganic compounds with which, if the MAK value is adhered to, there is no risk of foetal damage. There were a total of 13 changes and additions to the "BAT Value, BLW, BAR and EKA" section of the list.

In 2009, the Commission also published additional Biological Substance Reference Values (BAR values), which were first published in 2008. These values are not limits; instead, they define the "background exposure level" of a substance in the body. The BAR values permit comparisons between the level of exposure experienced by the general population and the exposure measured in the workplace. BAR values were determined for the following substances: acrylonitrile, soluble barium compounds, beryllium and its inorganic compounds and nickel and its compounds, plus o-toluidine and vinyl chloride.

As every year, once the current list has been submitted to the Federal Minister for Labour and Social Affairs, it is subject to a comments deadline. During this period, detailed written explanatory statements on every substance evaluated are requested from the Commission's Scientific Office by the end of the yea
'/>"/>

Contact: Cornelia Pretzer
Cornelia.Pretzer@dfg.de
49-228-885-4320
Deutsche Forschungsgemeinschaft
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Air Products Appoints John Marsland VP and GM of Global Liquid Bulk, Generated Gases, and Helium
2. Valley National Gases, LLC Acquires Beaver Valley Welding Supply, Inc: Sixth Acquisition for Valley National Gases This Fiscal Year
3. RxElite Awarded Anesthetic Gases Multi-Source Contract by Premier Inc., a Purchasing Network for More than 1,500 U.S. Hospitals and 49,000 Other Healthcare Sites
4. New Gas Analyzer Measures Two Gases at Once!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... , ... August 03, 2015 , ... ... ALS and amputation , AUGUST 3, 2015 – Since winning a South by ... 2015, Not Impossible – an organization whose mission is to develop technology for ...
(Date:8/3/2015)... ... 2015 , ... The art of preparing and cooking food comes naturally to ... young age, Nasreen Zereshki was extremely eager to cook Persian cuisine. Now that she ... My Persian Kitchen with the world. , Since Americans tend to be undereducated about ...
(Date:8/3/2015)... ... 2015 , ... AxoGen, Inc. (NASDAQ: AXGN), a leader in developing and marketing ... Healthcare Conference on Wednesday, August 12, 2015 at 9:45am (ET) at Le Parker Meridien ... Company’s presentation may be accessed via the investor relations section of the Company’s website. ...
(Date:8/3/2015)... OR (PRWEB) , ... August 03, 2015 , ... ... California’s Modoc National Forest, to Ahjumawi Lava Springs, California’s northernmost and among its ... California’s largest untapped ground water aquifers, whose main outflow is at Ahjumawi Lava ...
(Date:8/3/2015)... ... 2015 , ... A July 9 article from USA Today has ... to the American Dental Association. According to a study by the American Dental Association, ... in a single year to 2.2 million a year. Dentists and ADA officials all ...
Breaking Medicine News(10 mins):Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 2Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 4Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:AxoGen, Inc. to Present at the Wedbush Healthcare Conference 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 2Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 3
... characterization of renal transplant patients being weaned ... ... Data developed by Cylex in,conjunction with the University of Pittsburgh ... Canada, suggest,that cell-mediated immunity and anti-HLA antibody assays may be independent,measures ...
... COLUMBUS, Ohio Mothers play an important role in determining ... infants, according to new research. , A study of 97 ... care of their infants when they received active encouragement from ... important even after taking into account fathers and mothers views ...
... Three new studies published in the June 2008 ... on what role gender plays in the prognosis of ... the success rates of hearing aid implants in the ... wide variety of critical research being undertaken every day ...
... finds , , SATURDAY, May 31 (HealthDay News) -- ... survival in women with advanced breast cancer, new ... adding Avastin (bevacizumab) to the chemotherapy drug Taxol ... doubled progression-free survival. , Avastin is already approved ...
... Anti-angiogenesis drug prolonged progression-free survival, study finds , , ... drug Avastin to chemotherapy lengthened progression-free survival in ... , Previous studies have found that adding Avastin ... women with advanced breast cancer actually doubled progression-free ...
... Two Phase II studies demonstrated potential for pazopanib as a single,agent treatment ... -- In patients with stage I-III non-small cell lung cancer, ... monotherapy experienced a reduction in tumor volume ... an overall response rate of 35 percent. ...
Cached Medicine News:Health News:Cell-Mediated Immunity and Anti-HLA Antibody Tests Provide Insight to Immune Response in Renal Transplant Patients 2Health News:Cell-Mediated Immunity and Anti-HLA Antibody Tests Provide Insight to Immune Response in Renal Transplant Patients 3Health News:Mom's behavior key to dad's involvement in child care 2Health News:Mom's behavior key to dad's involvement in child care 3Health News:New research offers insight into oral cancer, chronic pediatric ear infections, and hearing health 2Health News:Avastin Added to Chemo Helps Women With Advanced Breast Cancer 2Health News:Avastin Added to Chemo Helps Women With Advanced Breast Cancer 3Health News:Avastin Added to Chemo Helps Women With Advanced Cancer 2Health News:Avastin Added to Chemo Helps Women With Advanced Cancer 3Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 2Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 3Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 4Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 5Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 6Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 7Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 8
(Date:8/3/2015)... -- VWR (NASDAQ: VWR ), a leading, ... redesign of its global website, www.vwr.com , to improve ... new site, guests will enjoy enhanced content on a modern ... country site now includes: , a simplified ... , the ability to search by discipline/industry. ...
(Date:8/3/2015)... 2015 /OFF HOLD OFF ... PIV757417 The following release: "Biotech Advancements Coupled with ... & Treatments for Critical-Care Patients With Severe Wound ... Aug 2015 12:30 GMT Cooperative research ... research and top-tier universities for identifying biotech solutions ...
(Date:8/3/2015)... JUPITER, Fla. , Aug. 3, 2015 /PRNewswire/ ... announced initiation of its second clinical development program ... drug candidate, CL-H1T.  CL-H1T contains ... is being developed as a treatment for migraine ... "Many patients with migraine headaches ...
Breaking Medicine Technology:VWR's New Website Redesign Provides Improved Functionality for Customers 2/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 2/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 3/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 4/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 5/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 6Charleston Laboratories, Inc. Initiates Patient Enrollment in a Phase 1 Study of Charleston's Second Product, CL-H1T 2
... and BIRMINGHAM, Ala., Sept. 6, 2011 ContinuumRx and ... the opening of a new home infusion ... Mississippi in a collaborative model designed to improve patient ... home. "This partnership will not only improve ...
... Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) today ... be presenting at the following September 2011 investor conferences: ... September 7, 2011 10:55am ET Rodman & ... September 12, 2011 10:50am ET UBS Global ...
Cached Medicine Technology:ContinuumRx Forms Healthcare Joint Venture with Mississippi Baptist Health Systems 2Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations 2
... Test is an immunochromatography based ... is designed for qualitative determination ... The presence of myoglobin in,serum ... higher can be detected in ...
... test kit is an immunochromatographic in vitro ... immunoglobulin E in human serum or plasma. ... with allergic pathologies. It may also be ... Rapid detection of IgE using InstaTest IgE ...
... physiological monitor offers a comprehensive array of ... for pediatric and neonate patients, to magnetic ... Veris is the first MR monitor designed ... and neonate patient monitoring. The new monitor ...
... AFP is an immunochromatographic in vitro assay ... in human serum. AFP is a protein ... 74,000 D. Its normal concentration in serum ... associated with hepatoma and ovarian, testicular and ...
Medicine Products: